Current Treatment Strategies for Irritable Bowel Syndrome - A Literature Review
DOI:
https://doi.org/10.12775/JEHS.2026.90.70580Keywords
irritable bowel syndrome, lowFOODMAP, antibiotic, probiotic, therapy, supplementation, physical activity, meditation, mindfulness, stressAbstract
Background. Irritable bowel syndrome is one of the most common chronic gastrointestinal disorders. This disease is diagnosed worldwide, although it is much more common in developed countries. The main role in the development of the disease is attributed to dysfunction of the brain-gut axis and factors such as intestinal microbiota dysbiosis and prolonged exposure to stress. The symptoms significantly reduce the quality of life of patients, which is why it is so important to develop clear recommendations for better control of the condition.
Aim. The aim of this study was to analyse and summarise current pharmacological and non-pharmacological strategies for treating irritable bowel syndrome.
Materials and methods. A review of the literature available in the PubMed, Google Scholar and Cochrane databases was conducted. Articles published between 2012-2025 were considered. Publications of low methodological quality and those containing incomplete data were excluded.
Results. According to research, the best dietary intervention is a low-FODMAP diet, but it should be followed under the supervision of an experienced dietitian. Probiotics should be considered as first-line medications. A growing number of publications point to the beneficial effects of psychotherapy, regular moderate-intensity physical activity, and healthy eating habits, especially regular consumption of small meals. The impact of quality sleep and stress management skills on prolonging IBS remission is also emphasized, but the scientific evidence is not yet strong enough.
Conclusions. Changes in diet and eating habits have been shown to be important in reducing symptoms and prolonging remission. There are many pharmacological options available, but there are no clear guidelines due to the complex pathomechanism of the disease. Currently, probiotics are the most recommended treatment. Herbal therapies, psychotherapy, mindfulness techniques, physical activity should be considered as additional support.
References
Abalo, R., Gallego-Barceló, P., & Gabbia, D. (2025). Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies. International Journal of Molecular Sciences, 26(19), 9345. https://doi.org/10.3390/ijms26199345
Bavani, N. G., Hajhashemy, Z., Saneei, P., Keshteli, A. H., Esmaillzadeh, A., & Adibi, P. (2022). The relationship between meal regularity with Irritable Bowel Syndrome (IBS) in adults. European Journal of Clinical Nutrition, 76(9), 1315–1322. https://doi.org/10.1038/s41430-022-01108-3
Bellini, M., Tonarelli, S., Nagy, A., Pancetti, A., Costa, F., Ricchiuti, A., De Bortoli, N., Mosca, M., Marchi, S., & Rossi, A. (2020). Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients, 12(1), 148. https://doi.org/10.3390/nu12010148
Bianco, A., Russo, F., Franco, I., Riezzo, G., Donghia, R., Curci, R., Bonfiglio, C., Prospero, L., D’Attoma, B., Ignazzi, A., Campanella, A., & Osella, A. R. (2023). Enhanced Physical Capacity and Gastrointestinal Symptom Improvement in Southern Italian IBS Patients following Three Months of Moderate Aerobic Exercise. Journal of Clinical Medicine, 12(21), 6786. https://doi.org/10.3390/jcm12216786
Black, C. J., Thakur, E. R., Houghton, L. A., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020). Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis. Gut, 69(8), 1441–1451. https://doi.org/10.1136/gutjnl-2020-321191
Burns, G. L., Talley, N. J., & Keely, S. (2022). Immune responses in the irritable bowel syndromes: Time to consider the small intestine. BMC Medicine, 20(1), 115. https://doi.org/10.1186/s12916-022-02301-8
Cara, K. C., Taylor, S. F., Alhmly, H. F., & Wallace, T. C. (2025). The effects of vitamin D intake and status on symptom severity and quality-of-life in adults with irritable bowel syndrome (IBS): A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition, 65(25), 4994–5007. https://doi.org/10.1080/10408398.2024.2400603
Chey, W. D., Shah, E. D., & DuPont, H. L. (2020). Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: A narrative review. Therapeutic Advances in Gastroenterology, 13, 1756284819897531. https://doi.org/10.1177/1756284819897531
Choi, Y., Youn, Y. H., Kang, S. J., Shin, J. E., Cho, Y. S., Jung, Y. S., Shin, S. Y., Huh, C. W., Lee, Y. J., Koo, H. S., Nam, K., Lee, H. S., Kim, D. H., Park, Y. H., Kim, M. C., Song, H. Y., Yoon, S.-H., Lee, S. Y., Choi, M., … the Korean Society of Neurogastroenterology and Motility. (2025). 2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility, 31(2), 133–169. https://doi.org/10.5056/jnm25007
Cozma-Petruţ, A., Loghin, F., Miere, D., & Dumitraşcu, D. L. (2017). Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World Journal of Gastroenterology, 23(21), 3771. https://doi.org/10.3748/wjg.v23.i21.3771
Crawford, G., Taylor, R., Young, D., & Hatton, C. G. (2023). Efficacy of the Enteroadsorbent Silicol®gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study. Gastroenterology Research and Practice, 2023, 1–14. https://doi.org/10.1155/2023/3432763
Cuffe, M. S., Staudacher, H. M., Aziz, I., Adame, E. C., Krieger-Grubel, C., Madrid, A. M., Ohlsson, B., Black, C. J., & Ford, A. C. (2025). Efficacy of dietary interventions in irritable bowel syndrome: A systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology, 10(6), 520–536. https://doi.org/10.1016/S2468-1253(25)00054-8
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M., Schemann, M., Schwille-Kiuntke, J., Simren, M., Zipfel, S., & Spiller, R. C. (2016). Irritable bowel syndrome. Nature Reviews Disease Primers, 2(1), 16014. https://doi.org/10.1038/nrdp.2016.14
Fernandes, A. J. T., Farrell, A. L., Naveh, S. V., & Chakraborty, S. (2024). Stress reduction and psychological therapy for IBS: A scoping review. Frontiers in Gastroenterology, 3, 1342888. https://doi.org/10.3389/fgstr.2024.1342888
Ford, A. C., Wright-Hughes, A., Alderson, S. L., Ow, P.-L., Ridd, M. J., Foy, R., Bianco, G., Bishop, F. L., Chaddock, M., Cook, H., Cooper, D., Fernandez, C., Guthrie, E. A., Hartley, S., Herbert, A., Howdon, D., Muir, D. P., Nath, T., Newman, S., … Everitt, H. A. (2023). Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): A randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 402(10414), 1773–1785. https://doi.org/10.1016/S0140-6736(23)01523-4
Futagami, S., Itoh, T., & Sakamoto, C. (2015). Systematic review with meta‐analysis: Post‐infectious functional dyspepsia. Alimentary Pharmacology & Therapeutics, 41(2), 177–188. https://doi.org/10.1111/apt.13006
Goodoory, V. C., Khasawneh, M., Black, C. J., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2023). Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology, 165(5), 1206–1218. https://doi.org/10.1053/j.gastro.2023.07.018
Groenendijk, D. W., Witteman, B. J., & Mulder, B. C. (2022). The Experiences of Female IBS Patients Concerning Physical Activity as Treatment Modality: A Qualitative Study. Qualitative Health Research, 32(11), 1690–1700. https://doi.org/10.1177/10497323221110109
Guo, Y.-B., Zhuang, K.-M., Kuang, L., Zhan, Q., Wang, X.-F., & Liu, S.-D. (2015a). Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut and Liver, 9(5). https://doi.org/10.5009/gnl13437
Guo, Y.-B., Zhuang, K.-M., Kuang, L., Zhan, Q., Wang, X.-F., & Liu, S.-D. (2015b). Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut and Liver, 9(5). https://doi.org/10.5009/gnl13437
Hanning, N., Edwinson, A. L., Ceuleers, H., Peters, S. A., De Man, J. G., Hassett, L. C., De Winter, B. Y., & Grover, M. (2021). Intestinal barrier dysfunction in irritable bowel syndrome: A systematic review. Therapeutic Advances in Gastroenterology, 14, 1756284821993586. https://doi.org/10.1177/1756284821993586
Herekar, A., Shimoga, D., Jehangir, A., Shahsavari, D., Yan, Y., Karunaratne, T. B., & Sharma, A. (2023). Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management. Clinical and Experimental Gastroenterology, Volume 16, 79–85. https://doi.org/10.2147/CEG.S384251
Huang, K.-Y., Wang, F.-Y., Lv, M., Ma, X.-X., Tang, X.-D., & Lv, L. (2023). Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World Journal of Gastroenterology, 29(26), 4120–4135. https://doi.org/10.3748/wjg.v29.i26.4120
Ingrosso, M. R., Ianiro, G., Nee, J., Lembo, A. J., Moayyedi, P., Black, C. J., & Ford, A. C. (2022). Systematic review and meta‐analysis: Efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 56(6), 932–941. https://doi.org/10.1111/apt.17179
Jafari, S., Atmani, A., Gohari, S., & Seifi, E. (2024). The Effect of Ondansetron on Improvement of Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea Domination: A Randomized Controlled Trial. Middle East Journal of Digestive Diseases, 16(3), 178–184. https://doi.org/10.34172/mejdd.2024.386
Jun, H., Ko, S.-J., Kim, K., Kim, J., & Park, J.-W. (2022). An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome. Frontiers in Pharmacology, 13, 894122. https://doi.org/10.3389/fphar.2022.894122
Karakan, T., Ozkul, C., Küpeli Akkol, E., Bilici, S., Sobarzo-Sánchez, E., & Capasso, R. (2021). Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders. Nutrients, 13(2), 389. https://doi.org/10.3390/nu13020389
Khalighi Sikaroudi, M., Soltani, S., Ghoreishy, S. M., Ebrahimi, Z., Shidfar, F., & Dehnad, A. (2024). Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: A systematic umbrella review with the meta-analysis of clinical trials. Food & Function, 15(10), 5195–5208. https://doi.org/10.1039/D3FO03717G
Khasawneh, M., Mokhtare, M., Moayyedi, P., Black, C. J., & Ford, A. C. (2025). Efficacy of gut–brain neuromodulators in irritable bowel syndrome: An updated systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 10(6), 537–549. https://doi.org/10.1016/S2468-1253(25)00051-2
Kuczka, N., Kala, M., Sygut, M., & Bednarczyk, M. (2025). Nutritional management of irritable bowel syndrome. https://doi.org/10.5281/ZENODO.17281931
Lembo, A. J., Lacy, B. E., Zuckerman, M. J., Schey, R., Dove, L. S., Andrae, D. A., Davenport, J. M., McIntyre, G., Lopez, R., Turner, L., & Covington, P. S. (2016). Eluxadoline for Irritable Bowel Syndrome with Diarrhea. New England Journal of Medicine, 374(3), 242–253. https://doi.org/10.1056/NEJMoa1505180
Li, C., Li, J., Zhou, Q., Wang, C., Hu, J., & Liu, C. (2024). Effects of Physical Exercise on the Microbiota in Irritable Bowel Syndrome. Nutrients, 16(16), 2657. https://doi.org/10.3390/nu16162657
Lovell, R. M., & Ford, A. C. (2012). Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis. Clinical Gastroenterology and Hepatology, 10(7), 712-721.e4. https://doi.org/10.1016/j.cgh.2012.02.029
Lu, S., Li, L., Zhuang, Y., Ye, F., Zhang, X., Chen, J., Sun, Z., & Dai, F. (2025). Night shift work increases the risk of developing irritable bowel syndrome: A prospective cohort study in the UK Biobank. Frontiers in Public Health, 13, 1651752. https://doi.org/10.3389/fpubh.2025.1651752
Mancabelli, L., Milani, C., Lugli, G. A., Turroni, F., Mangifesta, M., Viappiani, A., Ticinesi, A., Nouvenne, A., Meschi, T., Van Sinderen, D., & Ventura, M. (2017). Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses. Scientific Reports, 7(1), 9879. https://doi.org/10.1038/s41598-017-10663-w
Mou, J., Xu, L., Luo, Y.-F., Tao, Q., Wang, Z., Chen, M., & Zheng, H. (2025). Assessing the Efficacy and Safety of Multiple Drugs for IBS-C: A Systematic Review and Network Meta-Analysis. Journal of Gastrointestinal and Liver Diseases, 34(4), 503–509. https://doi.org/10.15403/jgld-6352
Naliboff, B. D., Smith, S. R., Serpa, J. G., Laird, K. T., Stains, J., Connolly, L. S., Labus, J. S., & Tillisch, K. (2020). Mindfulness‐based stress reduction improves irritable bowel syndrome (IBS) symptoms via specific aspects of mindfulness. Neurogastroenterology & Motility, 32(9), e13828. https://doi.org/10.1111/nmo.13828
Pavan, F., Yadav, S. S., Costantino, A., Dell’Era, A., Mastroianni, M., & Buoli, M. (2025). The Effectiveness of Yoga for Irritable Bowel Syndrome: A Systematic Review. Comprehensive Physiology, 15(5), e70061. https://doi.org/10.1002/cph4.70061
Pourkazem, T., Ghazanfari, A., & Ahmadi, R. (2023). Comparison of the Effectiveness of Mindfulness-Based Stress Reduction and Compassion-Focused Therapy on the Cognitive Emotion Regulation in Patients with Irritable Bowel Syndrome. Middle East Journal of Digestive Diseases, 15(4), 277–284. https://doi.org/10.34172/mejdd.2023.358
Pourkazem, T., Ghazanfari, A., & Ahmadi, R. (2024). Comparison of the Effectiveness of Mindfulness-Based Stress Reduction and Compassion-Focused Treatment on the Severity of Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome. Middle East Journal of Digestive Diseases, 16(1), 56–63. https://doi.org/10.34172/mejdd.2024.370
Qi, S., Zhao, M., Sun, Y., Boro, S., Rastogi, S., & Arora, B. (2025). Impact of vitamin D supplementation on symptom severity and quality of life in patients with irritable bowel syndrome: A meta-analysis. Advances in Clinical and Experimental Medicine, 34(7), 1091–1104. https://doi.org/10.17219/acem/191463
Qin, H.-Y. (2014). Impact of psychological stress on irritable bowel syndrome. World Journal of Gastroenterology, 20(39), 14126. https://doi.org/10.3748/wjg.v20.i39.14126
Rojas-Valverde, D., Bonilla, D. A., Gómez-Miranda, L. M., Calleja-Núñez, J. J., Arias, N., & Martínez-Guardado, I. (2023). Examining the Interaction between Exercise, Gut Microbiota, and Neurodegeneration: Future Research Directions. Biomedicines, 11(8), 2267. https://doi.org/10.3390/biomedicines11082267
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023). Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis. Frontiers in Endocrinology, 14, 1130689. https://doi.org/10.3389/fendo.2023.1130689
Schaper, S. J., & Stengel, A. (2022). Emotional stress responsivity of patients with IBS - a systematic review. Journal of Psychosomatic Research, 153, 110694. https://doi.org/10.1016/j.jpsychores.2021.110694
Schmulson, M. J., & Drossman, D. A. (2017). What Is New in Rome IV. Journal of Neurogastroenterology and Motility, 23(2), 151–163. https://doi.org/10.5056/jnm16214
Sebastián Domingo, J. J. (2022). Irritable bowel syndrome. Medicina Clínica (English Edition), 158(2), 76–81. https://doi.org/10.1016/j.medcle.2021.04.015
Shin, A., & Xu, H. (2024). Healthcare Costs of Irritable Bowel Syndrome and Irritable Bowel Syndrome Subtypes in the United States. American Journal of Gastroenterology, 119(8), 1571–1579. https://doi.org/10.14309/ajg.0000000000002753
Singh, M., Singh, V., Schurman, J. V., Colombo, J. M., & Friesen, C. A. (2020). The relationship between mucosal inflammatory cells, specific symptoms, and psychological functioning in youth with irritable bowel syndrome. Scientific Reports, 10(1), 11988. https://doi.org/10.1038/s41598-020-68961-9
Skrzydło-Radomańska, B., Prozorow-Król, B., Cichoż-Lach, H., Majsiak, E., Bierła, J. B., Kanarek, E., Sowińska, A., & Cukrowska, B. (2021). The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study. Nutrients, 13(3), 756. https://doi.org/10.3390/nu13030756
Someili, A., Mutaen, A. A., Alqahtani, A. M., Mobaraki, R. A., Mutaen, Y. A., Almuhaysin, G. S., Alhazmi, F. A., Tawhari, M. M., Maghfori, G. T., Ayyashi, S. M., Duhmi, N. A., Moraya, R., Mohrag, M., & Abdulrasak, M. (2025). Aspects on Self-Reported Symptoms in Irritable Bowel Syndrome: A Cross-Sectional Study. Gastroenterology Research, 18(1), 31–37. https://doi.org/10.14740/gr2010
Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., Kellow, J., Okeke, E., Quigley, E. M. M., Schmulson, M., Whorwell, P., Archampong, T., Adibi, P., Andresen, V., Benninga, M. A., … Palsson, O. S. (2021). Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology, 160(1), 99-114.e3. https://doi.org/10.1053/j.gastro.2020.04.014
Taghvaeinia, A., Karami, M., & Azizi, A. (2024). Comparison of the Effect of Dialectical Behavior Therapy, Acceptance and Commitment Therapy mindfulness-based Stress Reduction on Irritable Bowel Syndrome Symptoms, Quality of Life, Anxiety and Depression: A Pilot Randomized Controlled Trial. Psychiatric Quarterly, 95(1), 53–68. https://doi.org/10.1007/s11126-023-10058-3
Thakur, E. R., Shapiro, J. M., Wellington, J., Sohl, S. J., Danhauer, S. C., Moshiree, B., Ford, A. C., & Koch, K. (2024). A systematic review of yoga for the treatment of gastrointestinal disorders. Neurogastroenterology & Motility, e14915. https://doi.org/10.1111/nmo.14915
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., Moss-Morris, R., Yiannakou, Y., & Ford, A. C. (2021). British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut, 70(7), 1214–1240. https://doi.org/10.1136/gutjnl-2021-324598
Wang, J., Yang, P., Zhang, L., & Hou, X. (2021). A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis. Frontiers in Nutrition, 8, 683191. https://doi.org/10.3389/fnut.2021.683191
Wegierska, A. E., Charitos, I. A., Topi, S., Potenza, M. A., Montagnani, M., & Santacroce, L. (2022). The Connection Between Physical Exercise and Gut Microbiota: Implications for Competitive Sports Athletes. Sports Medicine, 52(10), 2355–2369. https://doi.org/10.1007/s40279-022-01696-x
Wei, L., Singh, R., Ro, S., & Ghoshal, U. C. (2021). Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open, 5(9), 976–987. https://doi.org/10.1002/jgh3.12528
Whelan, K., Ford, A. C., Burton-Murray, H., & Staudacher, H. M. (2024). Dietary management of irritable bowel syndrome: Considerations, challenges, and solutions. The Lancet Gastroenterology & Hepatology, 9(12), 1147–1161. https://doi.org/10.1016/S2468-1253(24)00238-3
Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024). The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients, 16(13), 2114. https://doi.org/10.3390/nu16132114
Zhang, T., Zhang, C., Zhang, J., Sun, F., & Duan, L. (2022). Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Frontiers in Cellular and Infection Microbiology, 12, 859967. https://doi.org/10.3389/fcimb.2022.859967
Zhong, Y., Bai, H., Zhang, Y., Yang, X., Zhang, T., Liu, X., Li, Z., Chen, H., & Lu, M. (2025). Association of rotating shift work with incident irritable bowel syndrome: A large population-based prospective cohort study. Frontiers in Public Health, 13, 1541122. https://doi.org/10.3389/fpubh.2025.1541122 https://doi.org/10.3389/fpubh.2025.1541122
Abalo, R., Gallego-Barceló, P., & Gabbia, D. (2025). Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies. International Journal of Molecular Sciences, 26(19), 9345. https://doi.org/10.3390/ijms26199345
Bavani, N. G., Hajhashemy, Z., Saneei, P., Keshteli, A. H., Esmaillzadeh, A., & Adibi, P. (2022). The relationship between meal regularity with Irritable Bowel Syndrome (IBS) in adults. European Journal of Clinical Nutrition, 76(9), 1315–1322. https://doi.org/10.1038/s41430-022-01108-3
Bellini, M., Tonarelli, S., Nagy, A., Pancetti, A., Costa, F., Ricchiuti, A., De Bortoli, N., Mosca, M., Marchi, S., & Rossi, A. (2020). Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients, 12(1), 148. https://doi.org/10.3390/nu12010148
Bianco, A., Russo, F., Franco, I., Riezzo, G., Donghia, R., Curci, R., Bonfiglio, C., Prospero, L., D’Attoma, B., Ignazzi, A., Campanella, A., & Osella, A. R. (2023). Enhanced Physical Capacity and Gastrointestinal Symptom Improvement in Southern Italian IBS Patients following Three Months of Moderate Aerobic Exercise. Journal of Clinical Medicine, 12(21), 6786. https://doi.org/10.3390/jcm12216786
Black, C. J., Thakur, E. R., Houghton, L. A., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020). Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis. Gut, 69(8), 1441–1451. https://doi.org/10.1136/gutjnl-2020-321191
Burns, G. L., Talley, N. J., & Keely, S. (2022). Immune responses in the irritable bowel syndromes: Time to consider the small intestine. BMC Medicine, 20(1), 115. https://doi.org/10.1186/s12916-022-02301-8
Cara, K. C., Taylor, S. F., Alhmly, H. F., & Wallace, T. C. (2025). The effects of vitamin D intake and status on symptom severity and quality-of-life in adults with irritable bowel syndrome (IBS): A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition, 65(25), 4994–5007. https://doi.org/10.1080/10408398.2024.2400603
Chey, W. D., Shah, E. D., & DuPont, H. L. (2020). Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: A narrative review. Therapeutic Advances in Gastroenterology, 13, 1756284819897531. https://doi.org/10.1177/1756284819897531
Choi, Y., Youn, Y. H., Kang, S. J., Shin, J. E., Cho, Y. S., Jung, Y. S., Shin, S. Y., Huh, C. W., Lee, Y. J., Koo, H. S., Nam, K., Lee, H. S., Kim, D. H., Park, Y. H., Kim, M. C., Song, H. Y., Yoon, S.-H., Lee, S. Y., Choi, M., … the Korean Society of Neurogastroenterology and Motility. (2025). 2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility, 31(2), 133–169. https://doi.org/10.5056/jnm25007
Cozma-Petruţ, A., Loghin, F., Miere, D., & Dumitraşcu, D. L. (2017). Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World Journal of Gastroenterology, 23(21), 3771. https://doi.org/10.3748/wjg.v23.i21.3771
Crawford, G., Taylor, R., Young, D., & Hatton, C. G. (2023). Efficacy of the Enteroadsorbent Silicol®gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study. Gastroenterology Research and Practice, 2023, 1–14. https://doi.org/10.1155/2023/3432763
Cuffe, M. S., Staudacher, H. M., Aziz, I., Adame, E. C., Krieger-Grubel, C., Madrid, A. M., Ohlsson, B., Black, C. J., & Ford, A. C. (2025). Efficacy of dietary interventions in irritable bowel syndrome: A systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology, 10(6), 520–536. https://doi.org/10.1016/S2468-1253(25)00054-8
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M., Schemann, M., Schwille-Kiuntke, J., Simren, M., Zipfel, S., & Spiller, R. C. (2016). Irritable bowel syndrome. Nature Reviews Disease Primers, 2(1), 16014. https://doi.org/10.1038/nrdp.2016.14
Fernandes, A. J. T., Farrell, A. L., Naveh, S. V., & Chakraborty, S. (2024). Stress reduction and psychological therapy for IBS: A scoping review. Frontiers in Gastroenterology, 3, 1342888. https://doi.org/10.3389/fgstr.2024.1342888
Ford, A. C., Wright-Hughes, A., Alderson, S. L., Ow, P.-L., Ridd, M. J., Foy, R., Bianco, G., Bishop, F. L., Chaddock, M., Cook, H., Cooper, D., Fernandez, C., Guthrie, E. A., Hartley, S., Herbert, A., Howdon, D., Muir, D. P., Nath, T., Newman, S., … Everitt, H. A. (2023). Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): A randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 402(10414), 1773–1785. https://doi.org/10.1016/S0140-6736(23)01523-4
Futagami, S., Itoh, T., & Sakamoto, C. (2015). Systematic review with meta‐analysis: Post‐infectious functional dyspepsia. Alimentary Pharmacology & Therapeutics, 41(2), 177–188. https://doi.org/10.1111/apt.13006
Goodoory, V. C., Khasawneh, M., Black, C. J., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2023). Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology, 165(5), 1206–1218. https://doi.org/10.1053/j.gastro.2023.07.018
Groenendijk, D. W., Witteman, B. J., & Mulder, B. C. (2022). The Experiences of Female IBS Patients Concerning Physical Activity as Treatment Modality: A Qualitative Study. Qualitative Health Research, 32(11), 1690–1700. https://doi.org/10.1177/10497323221110109
Guo, Y.-B., Zhuang, K.-M., Kuang, L., Zhan, Q., Wang, X.-F., & Liu, S.-D. (2015a). Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut and Liver, 9(5). https://doi.org/10.5009/gnl13437
Guo, Y.-B., Zhuang, K.-M., Kuang, L., Zhan, Q., Wang, X.-F., & Liu, S.-D. (2015b). Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut and Liver, 9(5). https://doi.org/10.5009/gnl13437
Hanning, N., Edwinson, A. L., Ceuleers, H., Peters, S. A., De Man, J. G., Hassett, L. C., De Winter, B. Y., & Grover, M. (2021). Intestinal barrier dysfunction in irritable bowel syndrome: A systematic review. Therapeutic Advances in Gastroenterology, 14, 1756284821993586. https://doi.org/10.1177/1756284821993586
Herekar, A., Shimoga, D., Jehangir, A., Shahsavari, D., Yan, Y., Karunaratne, T. B., & Sharma, A. (2023). Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management. Clinical and Experimental Gastroenterology, Volume 16, 79–85. https://doi.org/10.2147/CEG.S384251
Huang, K.-Y., Wang, F.-Y., Lv, M., Ma, X.-X., Tang, X.-D., & Lv, L. (2023). Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World Journal of Gastroenterology, 29(26), 4120–4135. https://doi.org/10.3748/wjg.v29.i26.4120
Ingrosso, M. R., Ianiro, G., Nee, J., Lembo, A. J., Moayyedi, P., Black, C. J., & Ford, A. C. (2022). Systematic review and meta‐analysis: Efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 56(6), 932–941. https://doi.org/10.1111/apt.17179
Jafari, S., Atmani, A., Gohari, S., & Seifi, E. (2024). The Effect of Ondansetron on Improvement of Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea Domination: A Randomized Controlled Trial. Middle East Journal of Digestive Diseases, 16(3), 178–184. https://doi.org/10.34172/mejdd.2024.386
Jun, H., Ko, S.-J., Kim, K., Kim, J., & Park, J.-W. (2022). An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome. Frontiers in Pharmacology, 13, 894122. https://doi.org/10.3389/fphar.2022.894122
Karakan, T., Ozkul, C., Küpeli Akkol, E., Bilici, S., Sobarzo-Sánchez, E., & Capasso, R. (2021). Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders. Nutrients, 13(2), 389. https://doi.org/10.3390/nu13020389
Khalighi Sikaroudi, M., Soltani, S., Ghoreishy, S. M., Ebrahimi, Z., Shidfar, F., & Dehnad, A. (2024). Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: A systematic umbrella review with the meta-analysis of clinical trials. Food & Function, 15(10), 5195–5208. https://doi.org/10.1039/D3FO03717G
Khasawneh, M., Mokhtare, M., Moayyedi, P., Black, C. J., & Ford, A. C. (2025). Efficacy of gut–brain neuromodulators in irritable bowel syndrome: An updated systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 10(6), 537–549. https://doi.org/10.1016/S2468-1253(25)00051-2
Kuczka, N., Kala, M., Sygut, M., & Bednarczyk, M. (2025). Nutritional management of irritable bowel syndrome. https://doi.org/10.5281/ZENODO.17281931
Lembo, A. J., Lacy, B. E., Zuckerman, M. J., Schey, R., Dove, L. S., Andrae, D. A., Davenport, J. M., McIntyre, G., Lopez, R., Turner, L., & Covington, P. S. (2016). Eluxadoline for Irritable Bowel Syndrome with Diarrhea. New England Journal of Medicine, 374(3), 242–253. https://doi.org/10.1056/NEJMoa1505180
Li, C., Li, J., Zhou, Q., Wang, C., Hu, J., & Liu, C. (2024). Effects of Physical Exercise on the Microbiota in Irritable Bowel Syndrome. Nutrients, 16(16), 2657. https://doi.org/10.3390/nu16162657
Lovell, R. M., & Ford, A. C. (2012). Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis. Clinical Gastroenterology and Hepatology, 10(7), 712-721.e4. https://doi.org/10.1016/j.cgh.2012.02.029
Lu, S., Li, L., Zhuang, Y., Ye, F., Zhang, X., Chen, J., Sun, Z., & Dai, F. (2025). Night shift work increases the risk of developing irritable bowel syndrome: A prospective cohort study in the UK Biobank. Frontiers in Public Health, 13, 1651752. https://doi.org/10.3389/fpubh.2025.1651752
Mancabelli, L., Milani, C., Lugli, G. A., Turroni, F., Mangifesta, M., Viappiani, A., Ticinesi, A., Nouvenne, A., Meschi, T., Van Sinderen, D., & Ventura, M. (2017). Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses. Scientific Reports, 7(1), 9879. https://doi.org/10.1038/s41598-017-10663-w
Mou, J., Xu, L., Luo, Y.-F., Tao, Q., Wang, Z., Chen, M., & Zheng, H. (2025). Assessing the Efficacy and Safety of Multiple Drugs for IBS-C: A Systematic Review and Network Meta-Analysis. Journal of Gastrointestinal and Liver Diseases, 34(4), 503–509. https://doi.org/10.15403/jgld-6352
Naliboff, B. D., Smith, S. R., Serpa, J. G., Laird, K. T., Stains, J., Connolly, L. S., Labus, J. S., & Tillisch, K. (2020). Mindfulness‐based stress reduction improves irritable bowel syndrome (IBS) symptoms via specific aspects of mindfulness. Neurogastroenterology & Motility, 32(9), e13828. https://doi.org/10.1111/nmo.13828
Pavan, F., Yadav, S. S., Costantino, A., Dell’Era, A., Mastroianni, M., & Buoli, M. (2025). The Effectiveness of Yoga for Irritable Bowel Syndrome: A Systematic Review. Comprehensive Physiology, 15(5), e70061. https://doi.org/10.1002/cph4.70061
Pourkazem, T., Ghazanfari, A., & Ahmadi, R. (2023). Comparison of the Effectiveness of Mindfulness-Based Stress Reduction and Compassion-Focused Therapy on the Cognitive Emotion Regulation in Patients with Irritable Bowel Syndrome. Middle East Journal of Digestive Diseases, 15(4), 277–284. https://doi.org/10.34172/mejdd.2023.358
Pourkazem, T., Ghazanfari, A., & Ahmadi, R. (2024). Comparison of the Effectiveness of Mindfulness-Based Stress Reduction and Compassion-Focused Treatment on the Severity of Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome. Middle East Journal of Digestive Diseases, 16(1), 56–63. https://doi.org/10.34172/mejdd.2024.370
Qi, S., Zhao, M., Sun, Y., Boro, S., Rastogi, S., & Arora, B. (2025). Impact of vitamin D supplementation on symptom severity and quality of life in patients with irritable bowel syndrome: A meta-analysis. Advances in Clinical and Experimental Medicine, 34(7), 1091–1104. https://doi.org/10.17219/acem/191463
Qin, H.-Y. (2014). Impact of psychological stress on irritable bowel syndrome. World Journal of Gastroenterology, 20(39), 14126. https://doi.org/10.3748/wjg.v20.i39.14126
Rojas-Valverde, D., Bonilla, D. A., Gómez-Miranda, L. M., Calleja-Núñez, J. J., Arias, N., & Martínez-Guardado, I. (2023). Examining the Interaction between Exercise, Gut Microbiota, and Neurodegeneration: Future Research Directions. Biomedicines, 11(8), 2267. https://doi.org/10.3390/biomedicines11082267
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023). Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis. Frontiers in Endocrinology, 14, 1130689. https://doi.org/10.3389/fendo.2023.1130689
Schaper, S. J., & Stengel, A. (2022). Emotional stress responsivity of patients with IBS - a systematic review. Journal of Psychosomatic Research, 153, 110694. https://doi.org/10.1016/j.jpsychores.2021.110694
Schmulson, M. J., & Drossman, D. A. (2017). What Is New in Rome IV. Journal of Neurogastroenterology and Motility, 23(2), 151–163. https://doi.org/10.5056/jnm16214
Sebastián Domingo, J. J. (2022). Irritable bowel syndrome. Medicina Clínica (English Edition), 158(2), 76–81. https://doi.org/10.1016/j.medcle.2021.04.015
Shin, A., & Xu, H. (2024). Healthcare Costs of Irritable Bowel Syndrome and Irritable Bowel Syndrome Subtypes in the United States. American Journal of Gastroenterology, 119(8), 1571–1579. https://doi.org/10.14309/ajg.0000000000002753
Singh, M., Singh, V., Schurman, J. V., Colombo, J. M., & Friesen, C. A. (2020). The relationship between mucosal inflammatory cells, specific symptoms, and psychological functioning in youth with irritable bowel syndrome. Scientific Reports, 10(1), 11988. https://doi.org/10.1038/s41598-020-68961-9
Skrzydło-Radomańska, B., Prozorow-Król, B., Cichoż-Lach, H., Majsiak, E., Bierła, J. B., Kanarek, E., Sowińska, A., & Cukrowska, B. (2021). The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study. Nutrients, 13(3), 756. https://doi.org/10.3390/nu13030756
Someili, A., Mutaen, A. A., Alqahtani, A. M., Mobaraki, R. A., Mutaen, Y. A., Almuhaysin, G. S., Alhazmi, F. A., Tawhari, M. M., Maghfori, G. T., Ayyashi, S. M., Duhmi, N. A., Moraya, R., Mohrag, M., & Abdulrasak, M. (2025). Aspects on Self-Reported Symptoms in Irritable Bowel Syndrome: A Cross-Sectional Study. Gastroenterology Research, 18(1), 31–37. https://doi.org/10.14740/gr2010
Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., Kellow, J., Okeke, E., Quigley, E. M. M., Schmulson, M., Whorwell, P., Archampong, T., Adibi, P., Andresen, V., Benninga, M. A., … Palsson, O. S. (2021). Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology, 160(1), 99-114.e3. https://doi.org/10.1053/j.gastro.2020.04.014
Taghvaeinia, A., Karami, M., & Azizi, A. (2024). Comparison of the Effect of Dialectical Behavior Therapy, Acceptance and Commitment Therapy mindfulness-based Stress Reduction on Irritable Bowel Syndrome Symptoms, Quality of Life, Anxiety and Depression: A Pilot Randomized Controlled Trial. Psychiatric Quarterly, 95(1), 53–68. https://doi.org/10.1007/s11126-023-10058-3
Thakur, E. R., Shapiro, J. M., Wellington, J., Sohl, S. J., Danhauer, S. C., Moshiree, B., Ford, A. C., & Koch, K. (2024). A systematic review of yoga for the treatment of gastrointestinal disorders. Neurogastroenterology & Motility, e14915. https://doi.org/10.1111/nmo.14915
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., Moss-Morris, R., Yiannakou, Y., & Ford, A. C. (2021). British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut, 70(7), 1214–1240. https://doi.org/10.1136/gutjnl-2021-324598
Wang, J., Yang, P., Zhang, L., & Hou, X. (2021). A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis. Frontiers in Nutrition, 8, 683191. https://doi.org/10.3389/fnut.2021.683191
Wegierska, A. E., Charitos, I. A., Topi, S., Potenza, M. A., Montagnani, M., & Santacroce, L. (2022). The Connection Between Physical Exercise and Gut Microbiota: Implications for Competitive Sports Athletes. Sports Medicine, 52(10), 2355–2369. https://doi.org/10.1007/s40279-022-01696-x
Wei, L., Singh, R., Ro, S., & Ghoshal, U. C. (2021). Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open, 5(9), 976–987. https://doi.org/10.1002/jgh3.12528
Whelan, K., Ford, A. C., Burton-Murray, H., & Staudacher, H. M. (2024). Dietary management of irritable bowel syndrome: Considerations, challenges, and solutions. The Lancet Gastroenterology & Hepatology, 9(12), 1147–1161. https://doi.org/10.1016/S2468-1253(24)00238-3
Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024). The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients, 16(13), 2114. https://doi.org/10.3390/nu16132114
Zhang, T., Zhang, C., Zhang, J., Sun, F., & Duan, L. (2022). Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Frontiers in Cellular and Infection Microbiology, 12, 859967. https://doi.org/10.3389/fcimb.2022.859967
Zhong, Y., Bai, H., Zhang, Y., Yang, X., Zhang, T., Liu, X., Li, Z., Chen, H., & Lu, M. (2025). Association of rotating shift work with incident irritable bowel syndrome: A large population-based prospective cohort study. Frontiers in Public Health, 13, 1541122. https://doi.org/10.3389/fpubh.2025.1541122 https://doi.org/10.3389/fpubh.2025.1541122
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sandra Michałek, Julia Rokosz, Katarzyna Sładek, Julianna Koczuk, Krzysztof Mazur, Alicja Trzepizur, Bartosz Wnorowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 14
Number of citations: 0
